These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

561 related articles for article (PubMed ID: 17580652)

  • 21. We don't need another hero.
    Badaracco JL
    Harv Bus Rev; 2001 Sep; 79(8):120-6, 162. PubMed ID: 11550628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Capitalizing on capabilities.
    Ulrich D; Smallwood N
    Harv Bus Rev; 2004 Jun; 82(6):119-27, 138. PubMed ID: 15202293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. No ordinary boot camp.
    Tichy NM
    Harv Bus Rev; 2001 Apr; 79(4):63-70, 166. PubMed ID: 11299694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Avoiding integrity land mines.
    Heineman BW
    Harv Bus Rev; 2007 Apr; 85(4):100-8, 142. PubMed ID: 17432157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What makes great boards great.
    Sonnenfeld JA
    Harv Bus Rev; 2002 Sep; 80(9):106-13, 126. PubMed ID: 12227143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Who really makes the big decisions in your company?
    Frisch B
    Harv Bus Rev; 2011 Dec; 89(12):104-11, 145. PubMed ID: 22250355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Getting IT right.
    Feld CS; Stoddard DB
    Harv Bus Rev; 2004 Feb; 82(2):72-9, 122. PubMed ID: 14971271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Making strategy: learning by doing.
    Christensen CM
    Harv Bus Rev; 1997; 75(6):141-6, 148-56. PubMed ID: 10174795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The 2003 HBR list. Breakthrough ideas for tomorrow's business agenda.
    Harv Bus Rev; 2003 Apr; 81(4):92-8, 124. PubMed ID: 12687923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Back where we belong.
    Critelli MJ
    Harv Bus Rev; 2005 May; 83(5):47-54, 152. PubMed ID: 15929403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conquering a culture of indecision.
    Charan R
    Harv Bus Rev; 2001 Apr; 79(4):74-82, 168. PubMed ID: 11299695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transforming corner-office strategy into frontline action.
    Gadiesh O; Gilbert JL
    Harv Bus Rev; 2001 May; 79(5):72-9, 164. PubMed ID: 11345913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are leaders portable?
    Groysberg B; McLean AN; Nohria N
    Harv Bus Rev; 2006 May; 84(5):92-100, 157. PubMed ID: 16649701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Managing for value. It's not just about the numbers.
    Haspeslagh P; Noda T; Boulos F
    Harv Bus Rev; 2001; 79(7):64-73, 144. PubMed ID: 11447618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A time for growth: an interview with Amgen CEO Kevin Sharer. Interview by Paul Hemp.
    Sharer K
    Harv Bus Rev; 2004; 82(7-8):66-74, 186. PubMed ID: 15241953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New thinking on how to link executive pay with performance.
    Rappaport A
    Harv Bus Rev; 1999; 77(2):91-101, 186. PubMed ID: 10387774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bringing customers into the boardroom.
    McGovern GJ; Court D; Quelch JA; Crawford B
    Harv Bus Rev; 2004 Nov; 82(11):70-80, 148. PubMed ID: 15559447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The passive-aggressive organization.
    Kaplan RS; Norton DP
    Harv Bus Rev; 2005 Oct; 83(10):82-92, 157. PubMed ID: 16250627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A letter to the chief executive.
    Fuller J
    Harv Bus Rev; 2002 Oct; 80(10):94-9, 130. PubMed ID: 12389464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The competitive advantage of corporate philanthropy.
    Porter ME; Kramer MR
    Harv Bus Rev; 2002 Dec; 80(12):56-68, 133. PubMed ID: 12510538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.